PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026Cureus0 citationsOpen Access

Global Research Trends in Gastric Cancer Epigenetics From 2005 to 2025

DYDidi YuanYLYanling LiHYHong Yi

Key Points

  • This study aims to assess the trends and current status of gastric cancer epigenetics research over two decades.
  • Conducted a search for publications on gastric cancer epigenetics from 2005 to 2025.
  • Utilized VOSviewer software for clustering and co-occurrence analysis of research outputs.
  • Applied CiteSpace software for burst analysis and timeline clustering of research trends.
  • Identified 4,655 papers on gastric cancer epigenetics, with China being the leading contributor.
  • Nanjing University published the most papers, while the USA showed the highest research centrality.
  • DNA methylation, tumor microenvironment, and immune infiltration emerged as key research themes.

Abstract

Background: Gastric cancer (GC) is one of the most common malignant tumors in the digestive tract, characterized by a high degree of malignancy and a poor prognosis. Complex disease heterogeneity, late diagnosis, and suboptimal treatment often lead to poor prognoses for patients. In addition to genetic alterations and environmental factors, changes in epigenetic mechanisms also play an important role in the occurrence and progression of GC. Revealing the current research status of epigenetics in GC has important guiding significance for the diagnosis and treatment of GC, as well as for future research directions. Methodology: In this study, we used specific keywords to search for publications related to gastric cancer epigenetics (GCE) published in the past 20 years in the Web of Science Core Collection database. The VOSviewer software (Version 1.6.20; Center for Science and Technology Studies (CWTS), Leiden University, Leiden, The Netherlands) was used to conduct clustering and co-occurrence analysis on countries, authors, institutions, and keywords in the publications. CiteSpace software (Version 6.3.1R6; Chaomei Chen, College of Computing and Informatics, Drexel University, Philadelphia, PA) was used for burst analysis and timeline clustering analysis. Result: A total of 4,655 papers on GC in the field of epigenetics were retrieved. China is the country with the largest number of published papers (n = 1,876), while the United States has the highest centrality (0.32). Nanjing University ranks first among all institutions in terms of the number of published papers (n = 175). The author Ushijima Toshikazu from Japan has the highest number of published papers (n = 48). Yuan Yuan is a representative author of the recent research hotspots. In the keyword ranking, keywords related to DNA methylation are relatively numerous. Tumor microenvironment and immune infiltration are key buzzwords with research potential. Conclusions: Based on bibliometric methods, this study provides new insights into the research progress of GC from the perspective of epigenetics and offers new ideas and inspirations for future GC research.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yuan et al. (2026) studied this question.

synapsesocial.com/papers/69cf5fe05a333a821460eb08https://doi.org/10.7759/cureus.106195
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p532024 · 7 citations
  2. 2Expression and prognostic potential of ribosome 18S RNA m6A methyltransferase METTL5 in gastric cancer2021 · 30 citations
  3. 3Severe induction of aberrant DNA methylation by nodular gastritis in adults2024 · 9 citations
  4. 4Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells2018 · 8 citations
  5. 5Comprehensive molecular phenotyping of ARID1A -deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities2023 · 34 citations